Commentary: Congress Should Protect This Medical Lifeline

In 1993, DuPont Co. sold $10.5 billion worth of the industrial fibers Dacron, Teflon, and Delrin. A mere $600,000 in sales, however, went to biomedical-implant manufacturers. But for more than eight years, DuPont ended up spending $50 million defending itself--successfully--against lawsuits involving a faulty jaw implant that contained 5 cents worth of Teflon. Deep pockets were the obvious target: The small implant maker went bankrupt soon after the suits were filed.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.